Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GALMED PHARMACEUTICALS LTD.

(GLMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 14312266,367,7--
Entreprise Value (EV)1 14312266,367,767,767,7
P/E ratio -12,6x-5,96x-2,30x-1,95x-1,99x-1,89x
Yield ------
Capitalization / Revenue 70,4x-----
EV / Revenue 70,4x-----
EV / EBITDA --6 071 475x-2 358 315x--2 288 060x-
Price to Book ------
Nbr of stocks (in thousands) 21 00421 12421 31225 084--
Reference price (USD) 6,835,783,112,702,702,70
Announcement Date 03/13/201903/12/202003/18/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 2,04-----
EBITDA --20,1-28,1--29,6-
Operating profit (EBIT)1 -10,7-22,4-30,2-36,2-42,6-51,3
Operating Margin -526%-----
Pre-Tax Profit (EBT)1 -9,78-20,5-28,8-35,7-42,2-50,8
Net income1 -9,86-20,5-28,8-35,7-42,2-50,8
Net margin -484%-----
EPS2 -0,54-0,97-1,35-1,39-1,35-1,43
Dividend per Share ------
Announcement Date 03/13/201903/12/202003/18/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 ------
EBITDA1 -9,74-9,12-8,40-6,80--
Operating profit (EBIT)1 -10,3-9,13-8,41-9,18-9,47-10,4
Operating Margin ------
Pre-Tax Profit (EBT)1 -10,3-8,91-8,40-9,08-9,37-10,2
Net income1 -10,3-8,91-8,40-9,08-9,37-10,2
Net margin ------
EPS2 -0,48-0,38-0,33-0,36-0,33-0,37
Dividend per Share ------
Announcement Date 03/18/202105/13/202108/05/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow -11,6-14,9-26,3---
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex 0,090,010,04-0,040,04
Capex / Sales 4,42%-----
Announcement Date 03/13/201903/12/202003/18/2021---
1 USD in Million
Key data
Capitalization (USD) 67 726 567
Number of employees 21
Free-Float 86,0%
Free-Float capitalization (USD) 58 241 362
Avg. Exchange 20 sessions (USD) 213 869
Average Daily Capital Traded 0,32%
EPS & Dividend